EVERSANA CONSULTING Named a Top Ranked Consulting Firm by Vault Across Asia Pacific

Feb 23, 2023

Xspray Pharma Partners with EVERSANA® for the U.S. Launch and Commercialization of its Lead Product, Dasynoc (XS004) for the Treatment of Chronic Myeloid Leukemia (CML) and Acute Lymphatic Leukemia (

Feb 23, 2023

Sounds of Science Podcast – Episode 13 on Rare Disease Day 2023

Feb 23, 2023

Posted by European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)

Azzur Group Appoints New Leadership for Los Angeles Consulting Office

Feb 22, 2023

Posted by Azzur of New England LLC

Ferrer acquires worldwide rights to ASN90, an O-GlcNAcase inhibitor from Asceneuron, exclusively to treat Progressive Supranuclear Palsy (PSP)

Feb 22, 2023

Posted by FERRER INTERNACIONAL

Babson Students Work to Improve Healthcare in Rwanda

Feb 21, 2023

Posted by Babson College

MassBio New Member Announcement—MERIT CRO

Feb 20, 2023

Posted by MERIT CRO